Intrexon | XON - PE Price to Earnings


Intrexon reported 7.54 in PE Price to Earnings for its fiscal quarter ending in December of 2021.





Pe Change Date
Amgen 18.6 0.53 Sep/2026
Anika Therapeutics 47.54 27.2 Jun/2024
Arrowhead Research 39.19 0 Jun/2026
AstraZeneca 24.63 0.71 Sep/2026
Bristol-Myers Squibb 10.44 5.7 Sep/2026
Gilead Sciences 17.68 4.18 Sep/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
Incyte 54.54 40.08 Sep/2026
Intrexon 7.54 221.44 Dec/2021
Ligand Pharmaceuticals 68.1 16.21 Sep/2026
MannKind 201.15 102.55 Mar/2026
Merck 34.36 2.11 Sep/2026
Novartis 19.17 3.24 Sep/2026
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Roche Holding 16.48 0.39 Jun/2026
Thermo Fisher Scientific 35.46 9.05 Sep/2026
Veracyte 29.55 13.22 Sep/2026
Xencor 29.92 3.22 Sep/2022